跳至主要内容
临床试验/NCT04669457
NCT04669457Enrolling By Invitation4 期

Prevention of Emergence Delirium in Pediatric Ambulatory Surgery: Single Blinded Randomized Control Study Comparing Intra-nasal Dexmedetomidine With Oral Midazolam.

University of Massachusetts, Worcester2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年4月27日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
Enrolling By Invitation
发起方
入组人数
60
试验地点
2
主要终点
Time to onset of pediatric delirium

研究概览

简要总结

Preventing emergent delirium in pediatric ambulatory surgery through preoperative use of intra-nasal Dexmedetomidine and oral Midazolam.

详细描述

Pediatric ambulatory patients will randomly be allocated to one of two groups. Group A which will receive Dexmedetomidine intra-nasally at a dose of 1 mcg/kg, approximately 15-25 minutes before entering the operating room or Group B which will receive Midazolam orally at a dose of 0.5 mg/kg (with a maximum dose of 20 mg), approximately 10-15 minutes before entering the operating room. Each subject will receive a Drug Acceptance scale, and Parental Separation Anxiety Scale (PSAS) mask Acceptance Scale to identify the differences in markers associated with pediatric delirium. End tidal Sevoflurane value during the surgery and at the time when patient leaves the OR, amount and dose of oral/rectal acetaminophen given in PACU, child's behavior for 48 hours post-operatively, and documented intake of oral analgesics will be collected to identify the reduced need for post-operative analgesia and behaviors associated with extended pediatric delirium.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Care Provider, Outcomes Assessor)

盲法说明

The surgeon and post-operative nurses will be masked to the group allocation. Masking will only be revealed if medically necessary.

入排标准

年龄范围
3 Months 至 9 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Subjects age 3 months to 9 years
  • Scheduled to undergo a myringotomy
  • American Society of Anesthesiologists (ASA) classification of I - II.

排除标准

  • Subjects with unrepaired cardiac defects, including cyanotic congenital heart disease.
  • Anyone age 10 years or older.
  • Anyone with an ASA classification of III or higher.
  • Non-English language speaker for whom short form consent is not available.

研究组 & 干预措施

Intra-nasal Dexmedetomidine

Experimental

Subjects will receive Dexmedetomidine intra-nasally in the preoperative area. It will be administered at a dose of 1 mcg/kg, approximately 15-25 minutes before entering the operating room.

干预措施: Intra-nasal Dexmedetomidine (Drug)

Oral Midazolam

Active Comparator

Subjects will receive Midazolam orally in the preoperative area. It will be administered at a dose of 0.5 mg/kg (with a maximum dose of 20 mg), approximately 10-15 minutes before entering the operating room.

干预措施: Oral Midazolam (Drug)

结局指标

主要结局

Time to onset of pediatric delirium

时间窗: Zero minutes to 48 hours

Time from when the patient is woken from anesthesia to the onset of delirium.

Time to offset of pediatric delirium

时间窗: Zero minutes to 48 hours

Time from onset of delirium to the offset of delirium.

Duration of pediatric delirium

时间窗: Zero minutes to 48 hours

Total time patient experiences delirium

次要结局

  • Drug Acceptance(10-25 minutes prior to surgery)
  • Parental Separation Anxiety Scale (PSAS)(0-48 hours)
  • Mask Acceptance Scale(1-10 minutes prior to surgery)
  • End tidal Sevoflurane value(0-12 hours)
  • Rescue analgesia in PACU(0-6 hours post surgery)
  • Home Behavior Analysis(12-48 hours)
  • Oral analgesic use(Two days post-operative)

研究者

发起方
University of Massachusetts, Worcester
申办方类型
Other
责任方
Principal Investigator
主要研究者

R. Ian Richmond

Assistant Professor, Director of Clinical Operations, Dept of Anesthesiology and Perioperative Medicine

University of Massachusetts, Worcester

研究点 (2)

Loading locations...

相似试验